Work

Combination of irinotecan and bevacizumab for heavily pretreated recur- rent ovarian cancer: A phase II trial

Year: 2013

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2013.04.085

Authors: H. Ling, F. Muggia, J. Speyer, J. Curtin, S. Blank, L. Boyd, B. Pothuri, X. Li, J. Goldberg, A. Tiersten

Institution: New York University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2163210145

FWCI:

Cites:

Cited by: 1

Related to: 10